Organon & Co | Satış Brüt Kar



Gross Profit On Sales Değişiklik Tarih
Adcock Ingram Holdings ZAR 1.61B 802K 2024-06
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Celltrion KRW 463.41B 95.59B 2024-09
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Ecofibre AUD 2.08M 4.33M 2024-06
Gilead Sciences USD 5.99B 17M 2024-12
Glaxosmithkline GBP 5.6B 94M 2024-12
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 110.32M 24.65M 2024-06
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 13.36M 2.36M 2024-06
Merck USD 11.92B 852M 2024-12
Novartis USD 10.24B 313M 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Organon & Co USD 896M 27M 2024-12
Pharma Mar EUR 47.05M 3.4M 2024-12
Qiagen NV USD 349.8M 19.17M 2024-12
Sartorius EUR 345.1M 43.2M 2024-09
Sino Biopharmaceutical CNY 6.51B 2.67B 2024-06
Tilray USD 61.22M 1.51M 2024-11



Organon & Co Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2025.